ClinicalTrials.gg
Not yet recruitingNCT07905014Updated Oct 29, 2026

Surface Electromyographic Analysis of Scapular Stabilizer Muscle in Postural Hyperkyphosis

An interventional study of Traditional Postural Exercises and Schroth-Based Corrective Exercises in Hyperkyphosis, sponsored by Istinye University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Istinye University · Not applicable, Interventional, and Basic science

Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Postural hyperkyphosis is characterized by an excessive thoracic kyphotic curvature and may alter scapular positioning, muscular balance, and upper extremity biomechanics. Scapular stabilizer muscles play an important role in maintaining postural alignment and ensuring efficient force transmission throughout the kinetic chain. Exercise-based interventions, including conventional postural exercises and the Schroth method, are commonly used in the conservative management of postural hyperkyphosis. However, evidence directly comparing scapular stabilizer muscle activation during these exercise approaches remains limited.

The Schroth method is a three-dimensional corrective exercise approach incorporating active spinal elongation, postural correction, rotational breathing, and isometric muscle activation, whereas conventional postural exercises primarily focus on muscle strengthening, stretching, spinal mobility, and postural alignment.

The aim of this study is to compare the activation levels of scapular stabilizer muscles, including the serratus anterior, rhomboids, middle trapezius, and lower trapezius, during Schroth-based corrective exercises and conventional postural exercises in young adults with postural hyperkyphosis using surface electromyography. Isometric muscle strength of the same muscle groups will also be evaluated.

The study will focus on immediate muscle activation patterns during exercise performance rather than long-term treatment outcomes. The findings are expected to provide objective evidence regarding muscle recruitment patterns during different corrective exercise approaches and contribute to the development of more individualized and targeted exercise programs for individuals with postural hyperkyphosis.

02

Conditions studied

  • Hyperkyphosis

Browse trials for

Keywords

  • Scapular Muscle Activation
  • Surface Electromyography
  • Postural Hyperkyphosis
03

In context

Kyphosis

132 studies on the registry are indexed under Kyphosis; 31 are open to participants now.

This study's planned enrollment of 50 is above the median of 44 across 82 interventional studies indexed under Kyphosis.

Browse Kyphosis studies →

Lead sponsor

Istinye University is the lead sponsor of 221 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 35 years.
  • Thoracic kyphosis angle between 45° and 60° on lateral radiographic assessment or a kyphosis index score of 13 or higher measured using the Flexicurve method.

Exclusion criteria

Exclusion Criteria:

  • Presence of congenital or rigid spinal deformities or structural abnormalities.
  • History of major musculoskeletal surgery or trauma, particularly involving the spine.
  • Receipt of physiotherapy interventions targeting the spinal region within the previous six months.
  • (BMI) ≥ 30 kg/m².
  • Diagnosed hearing impairments.
  • Difficulty understanding or following verbal instructions.
  • Presence of systemic diseases, including diabetes mellitus, hypothyroidism, infections, or .
  • Presence of neurological disorders.
  • Presence of active rheumatic diseases.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Sequence AB: Traditional-Schroth Sequence

    Participants allocated to this sequence will perform traditional postural exercises (prone T and prone I exercises) during the first session, followed by Schroth-based corrective exercises (Kneeling Between Chairs and Standing in a Doorway) during the second session, with a two-day interval between sessions. Scapular stabilizer muscle activation will be assessed using surface electromyography (sEMG) during both exercise protocols.

    Other: Traditional Postural Exercises · Other: Schroth-Based Corrective Exercises

  • Experimental
    Sequence BA: Schroth-Traditional Sequence

    Participants allocated to this sequence will perform Schroth-based corrective exercises (Kneeling Between Chairs and Standing in a Doorway) during the first session, followed by traditional postural exercises (prone T and prone I exercises) during the second session, with a two-day interval between sessions. Scapular stabilizer muscle activation will be assessed using surface electromyography (sEMG) during both exercise protocols.

    Other: Traditional Postural Exercises · Other: Schroth-Based Corrective Exercises

Interventions

  • OtherTraditional Postural Exercises

    The traditional postural exercise protocol consists of two prone exercises targeting the scapular stabilizer muscles: prone T and prone I exercises. During the prone T exercise, participants will lie in a prone position with their shoulders abducted to 9

  • OtherSchroth-Based Corrective Exercises

    The Schroth-based corrective exercise protocol consists of two exercises: Kneeling Between Chairs and Standing in a Doorway. During the Kneeling Between Chairs exercise, participants will maintain a kneeling position between two chairs, with their upper extremities supported on the chairs. Active axial elongation, postural correction, scapular stabilization, and rotational angular breathing will be performed according to Schroth principles. During the Standing in a Doorway exercise, participants will stand in a doorway with their upper extremities positioned against the doorframe at shoulder level. Active axial elongation, scapular stabilization, thoracic expansion, and rotational angular breathing will be performed while maintaining the corrected posture. Scapular stabilizer muscle activation will be continuously recorded using surface electromyography during the exercises.

06

What researchers measure

Primary outcomes

  1. Scapular Stabilizer Muscle Activation

    Scapular stabilizer muscle activation will be assessed bilaterally using wireless surface electromyography (sEMG) during Schroth-based corrective and conventional postural exercises. Muscle activation of the serratus anterior, upper trapezius, middle trapezius, and lower trapezius will be recorded. EMG signals will be sampled at 1000-2000 Hz and band-pass filtered between 20-500 Hz. Root mean square (RMS) values obtained from the middle three seconds of the isometric holding phase will be normalized to each muscle's maximum voluntary isometric contraction (MVIC) and expressed as a percentage of MVIC (%MVIC). Mean normalized muscle activation values across three sets will be used to compare the two exercise approaches.

    Time frame: 4 weeks

Secondary outcomes

  1. Muscle Strength

    Bilateral isometric muscle strength of the serratus anterior, upper trapezius, middle trapezius, and lower trapezius will be assessed using a digital handheld dynamometer with the make-test technique. Each muscle will be evaluated through three maximal voluntary isometric contractions lasting five seconds each, with 30-second rest intervals between repetitions and one-minute rest intervals between muscles. The mean of the two highest measurements will be used for analysis. Higher values indicate greater isometric muscle strength.

    Time frame: 4 weeks

  2. Thoracic Kyphosis Angle (Cobb Method)

    Thoracic kyphosis angle will be assessed using the Cobb method on standing lateral thoracic radiographs. The angle between the superior endplate of the T1 vertebra and the inferior endplate of the T12 vertebra will be measured in degrees (°). All radiographic measurements will be performed by the same radiologist. Greater angular values indicate increased thoracic kyphosis.

    Time frame: 4 weeks

  3. Kyphosis Index

    Thoracic kyphosis will be assessed non-invasively using a flexible curve ruler (Flexicurve). With the participant standing upright, the ruler will be molded along the spinal curvature and transferred onto paper. The thoracic curvature length (L) and maximum kyphosis height (H) will be measured. The Kyphosis Index will be calculated using the formula: (H / L) × 100. Higher scores indicate greater thoracic curvature, and a score of 13 or higher will be considered indicative of hyperkyphosis.

    Time frame: 4 weeks

07

Study locations

1 site
  • Kubra KARDES
    Istanbul, 34010, Turkey (Türkiye)
    • Kubra Kardes, Asst.Prof · Contactkubrakoce@gmail.com · 05387115631
    • Beyza Tanriogen, Res. Asst. · Sub investigator
    • Ayse Zengin Alpozgen, Assoc. Prof. · Sub investigator
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jan 2027, 2 months later.

Of 56 non-industry interventional studies with no phase under Kyphosis, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's planned 2 months is below that.

Counting every sponsor, half of 58 studies reached it within 9 months; a quarter within 4 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2026
First posted
Oct 29, 2026
StartEst.
Oct 30, 2026
Primary completionEst.
Jan 15, 2027
CompletionEst.
Feb 15, 2027
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07905014
Lead sponsor
Istinye University
Responsible party
Kubra Kardes (Asst. Prof., Istinye University) — Principal investigator
First posted
Oct 29, 2026
Start date
Oct 30, 2026 (estimated)
Primary completion
Jan 15, 2027 (estimated)
Completion
Feb 15, 2027 (estimated)
Last update
Oct 29, 2026

Study contacts

Kubra Kardes, Asst. Prof.
Contact
kubrakoce@gmail.com
05387115631

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion